BACKGROUND: Pulmonary hypertension (PH) is a well-known complication of chronic obstructive pulmonary disease (COPD). It remains unclear whether exercise parameters can be used to discriminate between COPD patients with associated PH (COPD-PH) and COPD patients without associated PH (COPD-nonPH). OBJECTIVE: To study whether the existence of pulmonary hypertension in COPD is related to characteristic findings in gas exchange and circulatory parameters during cardiopulmonary exercise testing (CPET). METHODS: We retrospectively analyzed CPET data in 25 COPD patients in whom right heart catheterization had been performed. Differences were assessed between COPD-PH and COPD-nonPH patients in peak oxygen uptake (VO(2) peak), ventilatory efficiency (VE/VCO(2)), oxygen pulse, maximal ventilation and pulse oximetry (S(p)O(2)). RESULTS: PH was found in 10 of 25 patients (mP(pa) = 33 +/- 7 mm Hg), in 15 patients mean pulmonary artery pressure (mP(pa)) was below 25 mm Hg (18 +/- 3 mm Hg). CPET in COPD-PH was characterized by a higher VE/VCO(2) at nadir, a higher VE/VCO(2) slope, and a lower S(p)O(2) at rest and during exercise, but values in both groups were overlapping considerably. In the whole group mP(pa) was associated with resting P(a)O(2) (r = -0.70, p < 0.001), VE/VCO(2) nadir (r = 0.43, p < 0.05), and inversely related to S(p)O(2) at rest and during exercise (r = -0.58 and r = -0.64, p < 0.01, respectively). CONCLUSION: Although CPET characteristics showed a large overlap in both groups, the existence of PH in COPD is associated with a significantly reduced ventilatory efficiency during CPET. However, a low S(p)O(2) at rest and a further decrease during exercise similarly suggest the presence of PH in COPD. Copyright 2007 S. Karger AG, Basel.
BACKGROUND:Pulmonary hypertension (PH) is a well-known complication of chronic obstructive pulmonary disease (COPD). It remains unclear whether exercise parameters can be used to discriminate between COPD patients with associated PH (COPD-PH) and COPD patients without associated PH (COPD-nonPH). OBJECTIVE: To study whether the existence of pulmonary hypertension in COPD is related to characteristic findings in gas exchange and circulatory parameters during cardiopulmonary exercise testing (CPET). METHODS: We retrospectively analyzed CPET data in 25 COPD patients in whom right heart catheterization had been performed. Differences were assessed between COPD-PH and COPD-nonPH patients in peak oxygen uptake (VO(2) peak), ventilatory efficiency (VE/VCO(2)), oxygen pulse, maximal ventilation and pulse oximetry (S(p)O(2)). RESULTS: PH was found in 10 of 25 patients (mP(pa) = 33 +/- 7 mm Hg), in 15 patients mean pulmonary artery pressure (mP(pa)) was below 25 mm Hg (18 +/- 3 mm Hg). CPET in COPD-PH was characterized by a higher VE/VCO(2) at nadir, a higher VE/VCO(2) slope, and a lower S(p)O(2) at rest and during exercise, but values in both groups were overlapping considerably. In the whole group mP(pa) was associated with resting P(a)O(2) (r = -0.70, p < 0.001), VE/VCO(2) nadir (r = 0.43, p < 0.05), and inversely related to S(p)O(2) at rest and during exercise (r = -0.58 and r = -0.64, p < 0.01, respectively). CONCLUSION: Although CPET characteristics showed a large overlap in both groups, the existence of PH in COPD is associated with a significantly reduced ventilatory efficiency during CPET. However, a low S(p)O(2) at rest and a further decrease during exercise similarly suggest the presence of PH in COPD. Copyright 2007 S. Karger AG, Basel.
Authors: Ross Arena; Marco Guazzi; Jonathan Myers; Daniel Grinnen; Daniel E Forman; Carl J Lavie Journal: Expert Rev Respir Med Date: 2011-04 Impact factor: 3.772
Authors: Laura Fossati; Séverine Müller-Mottet; Elisabeth Hasler; Rudolf Speich; Konrad E Bloch; Lars C Huber; Silvia Ulrich Somaini Journal: Lung Date: 2014-10-28 Impact factor: 2.584
Authors: Karin Vonbank; Georg Christian Funk; Beatrice Marzluf; Bernhard Burian; Rolf Ziesche; Leopold Stiebellehner; Ventzislav Petkov; Paul Haber Journal: Wien Klin Wochenschr Date: 2008 Impact factor: 1.704
Authors: José González-Costello; Hilary F Armstrong; Ulrich P Jorde; Anna C Bevelaqua; Laurie Letarte; Byron M Thomashow; Matthew N Bartels Journal: Respir Physiol Neurobiol Date: 2013-05-10 Impact factor: 1.931
Authors: Marco Guazzi; Volker Adams; Viviane Conraads; Martin Halle; Alessandro Mezzani; Luc Vanhees; Ross Arena; Gerald F Fletcher; Daniel E Forman; Dalane W Kitzman; Carl J Lavie; Jonathan Myers Journal: Circulation Date: 2012-09-05 Impact factor: 29.690